Introduction
Tissue fixation for immunocytochemistry is often difficult because it must reach two goals that are usually not compatible: preservation of good tissue ultrastructure and preservation of sufficient immunoreactivity against the molecule under detection. Immunoreactivity against intracellular protein or peptide antigens depends not only on in situ fixation and on preservation of their antigenicity but also on their accessibility to immunoreagents. To achieve an acceptable compromise between these opposite objectives, it is usually recommended to test fixatives, including 4% paraformaldehyde and 0.05-0.5% glutaraldehyde (1). However, optimal ultrastructural preservation of brain tissue is best achieved by using a fixative with a high concentration of glutaraldehyde (I->%). Only few pre-embedding immunocytochemical studies have been carried out to detect proteins on CNS tissue fixed with such highly tissue. Of all antigens tested, only choline acetyltransferase, phenylethanolamine-N-methyl transferase, and neuropeptide Y were detected with lower sensitivity than after paraformaldehyde fixation, which was attributed to a rather restricted penetration of the primary antibody into glutaraldehyde-fued tissue sections. These results indicate that glutaraldehyde may be envisaged as a possible fixative for optimal immunocytochemical detection of any tissue antigen at the electron microscopic level, including antigens which, on the basis of results obtained after fixation with paraformaldehyde-glutaraldehyde mixtures, were considered highly sensitive to glutaraldehyde furation. (JHistochem Cyrochem 43:1285-1291, 1995) KEY WORDS: Immunocytochemistry; Ultrastructure; Histological fixation; Electron microscopy; Glutaraldehyde; Neural tissue; Rat. concentrated glutaraldehyde (e.g., 2,3), since most protein antigens are considered highly sensitive to this fixative, which is known to alter protein structure (1). Moreover, glutaraldehyde restricts accessibility of antigens to immunoreagents by cross-linking proteins in the cytoplasm and in the extracellular space.
Nevertheless, a few studies have reported successful 'immunostaining for peptides after brain fixation with high concentrations of glutaraldehyde. This was the case, in particular, for substance P (1,4), thyrotropin-releasing hormone (TRH) (4) . calcitonine generelated peptide (CGRP) ( 5 ) , and enkephalins (6). In the present study we tested several antibodies against different peptides or proteins (enzymes, phosphoproteins, intermediate filaments, synaptic vesicle proteins, a lectin) for pre-embedding immunocytochemistry after fixation of rat or mouse brain with 3.5% glutaraldehyde.
In most cases, immunoreactivity was equivalent to that observed in tissue sections fixed with paraformaldehyde, or even improved compared to those sections.
Materials and Methods
Animals. Tissue was prepared from five adult male Sprague-Dawley rats (Charles River; Montreal. Quebec, Canada) weighing 300-350 g, two newborn (P5) female rats, three normal adult mice (C57BL; Charles River), and three mice transgenic for the human form of the neurofilament protein NF-L (hNF-L) (7) . Three of the rats had received single injections of Pbaseolus vufguns leukoagglutinin (PHA-L) into the globus pallidus 2 weeks before sacrifice according to the technique of Gerfen and Sawchenko (8) . The animals were used in accordance with the guidelines of the Animal Care Committee of the Universiti de Montreal.
Antibodies. Antibodies against the following antigens were used at dilutions yielding optimal signal-to-noise ratios in paraformaldehyde-fixed brain tissue: tyrosine hydroxylase (TH, monoclonal from Boeghringer-Mannheim, Mannheim, Germany, 1:200; polyclonal from Pel-Freez, Rogers, AR, 1:1000); phenylethanolamine-N-methyl transferase [PNMT (9); 1:1000]; choline acetyltransferase [ChAT (10) ; 1:500]; glutamic acid decarboxylase (GAD; Chemicon. Temecula, CA; 1:5000); dopamine-and adenosine-regulated phosphoprotein-32 ; 1:40,000; PHA-L (Vector, Burlingame, CA; 1:200); glial fibrillary acidic protein (GFAP, polyclonal from Dakopatts, Glostrup. Denmark; 1:2000; monoclonal from Sigma, St Quentin-Fallavier, France; 1:2000); vimentin (clone V9. Boehringer-Mannheim; 1:lOO); neurofilament light protein (NF-L, clone NR4. Boehringer-Mannheim, recog nizing mouse, rat and human NF-L; 1:lOO; clone DP5-1-12, Bio-Can. Mississauga, Ontario, Canada, recognizing human but not mnuse nor rat NF-L; 1:lOO); synaptophysin (12) (1:lOOO); synapsin I (12) (1:2000); neuropeptide Y [NPY (13) ; 1:5000]; vasopressin [AVP 14; 1:2000] ; vasoactive intestinal peptide (VIP, Peninsula, Merseyside, UK; 1:ZOOO); serotonin-glutaraldehyde-protein conjugate [>-HT (15) ; 1:5000].
Each antibody was tested on sections from at least three rats or mice fixed with glutaraldehyde in separate sessions Procedure. Mice and rats were deeply anesthetized with sodium pentobarbital 65 mgikg, i.p. (Somnotol; MTC Pharmaceuticals, Cambridge, Ontario. Canada) and perfused through the heart with 20-50 ml of 0.12 M sodium phosphate buffer (PB, pH 7.4, containing 0.002% CaC12, 35°C). followed by 3.5% glutaraldehyde at 4% (EM grade; Mecalab. Montreal, Quebec. Canada) in PB for 10-15 min. The brains were removed and immersed in the same fixative for 1-4 hr at 4°C. Consecutive 50-pm-thick sections for either light or electron microscopy were cut with a vibratome, rinsed in PB (three times for 5 min), and treated for 20 min with 1% sodium borohydride (Sigma; St Louis, MO) (3) in PB. After several PB washes, sections for electron microscopy were cryoprotected in PB containing 35 % sucrose and 14% glycerol, frozen for 15 sec in isopentane pre-cooled to -50°C with liquid nitrogen, and thawed in PB at room temperature (RT) to increase the penetration of immunoreagents. All sections were then processed floating freely for immunolabeling as follows. After pre-incubation ( 2 hr at RT) in PBS containing 10% normal horse or goat serum (Vector), 1% bovine serum albumin (Sigma), 0.1% sodium azide (Sigma) and, for light microscopy, 0.5% Triton X-100, they were incubated in the same solution containing the primary antibody, first at RT (overnight), then at 4°C (36-48 hr). They were stained with the ABC method (15) , and reacted in 3,3'-diaminobenzidine (Sigma) and H202, Dual immunostaining (5-HT-TH) was performed according to the technique of Chan et al. (16) with a monoclonal antibody against 5-HT-glutaraldehyde-protein conjugate (17) (see 18 for technical details) and the polyclonal antiserum against TH. Sections were then incubated to visualize TH with goat anti-rabbit IgG labeled with 1-nm gold particles (AuroProbe One; Amersham, Arlington Heights, IL) for 2 hr at RT, followed by washes in 0. 12, 500) in the parietal area of cerebral cortex, in the basal ganglia, and in the hypothalamus. The labeling obtained in light microscopy was compared to that previously obtained repeatedly (several rats in each case) with the same primary antibodies (same batches) on brain sections fixed with 4% formaldehyde with or without 0.05-0.2% glutaraldehyde and stained using the same immunolabeling procedure (without sodium borohydride treatment). It was graded by two or three independent observers as faint (+ ) to strong (+ + + + ), based on staining intensity and number of immunoreactive elements (both parameters being clearly correlated, they were pooled into one measure). In addition, penetration of antibodies into vibratome sections processed for electron microscopy (freeze-thawed) was assessed in semi-thin sections cut perpendicular to the initial vibratome sections.
Results
As summarized in Table 1 , all antibodies gave a positive specific signal in brain sections fixed with 3.5% glutaraldehyde and treated with Triton X-100 ( Figure 1 ). Background staining was efficiently reduced by the pre-treatment with sodium borohydride (3). Table  1 also lists the types of cell profiles that were labeled in each case. The specificity of immunolabeling was confirmed in every case by the similarity with the staining pattern reported previously for the same antibodies in the studies cited below. Antibodies against synaptic vesicle-associated proteins stained only axonal varicosities (e.g., Figure 2B ) (12.20) . The one against GFAP labeled only astrocytes ( Figure IC) (21) . and the one against vimentin labeled radial glia in newborn rat as well as the ependyma and endothelium in newborn and adult rats. All other antibodies against endogenous antigens labeled neuronal perikarya, dendrites, and varicose axons in the cerebral cortex, the basal ganglia, and/or the hypothalamus, according to the known distribution of the corresponding molecule. PHA-L was also present in perikarya and dendrites in globus pallidus (injection site) and in cerebral cortex and striatum (retrograde transport), as well as in axon terminals (projection territories).
In most cases, the results were similar in glutaraldehyde-and in paraformaldehyde-fixed brain tissue. The only differences concerned ChAT (22). NPY, PNMT, and NF-L (23,24) immunoreactivity. After glutaraldehyde fixation, ChAT ( Figure ID) , NPY, and PNMT staining was less intense than after paraformaldehyde fixation whereas, conversely, NF-L staining ( Figure 1A) (23,24) and, to a lesser extent, hNF-L staining in transgenic mice (24) was significantly higher.
Without treatment with detergent, the penetration of immunostaining, as evaluated in semi-thin sections cut perpendicular to the initial vibratome sections, varied depending on the antibody and/or the antigen considered (not illustrated). It was noteworthy, in particular, that GAD-and synaptophysin-labeled elements were restricted to the surface of the section whereas elements immunopositive for TH after application of polyor monoclonal antibodies were found deep into the core of the vibratome sections.
At the electron microscopic level, the ultrastructure of the neu- The immunolabeling was graded in sections prepared for light microscopy and treated with Triton X-100 as faint ( + ) to very high ( + + + + ), taking into account the intensity of staining and the number of immunoreactive elements. Glutar. brain tissue fixed with 3.5 % glutaraldehyde; pForm, brain tissue fmed with 4% paraformaldehyde ( t 0.05-0.2% glutaraldehyde).
ral tissue was well preserved, as expected, after fixation with glutaraldehyde. Immunolabeled nerve terminals were detected in ultrathin sections from the core of the vibratome slices in some cases (e.g., TH) and only from the surface of the slices in other cases (e.g., GAD, ChAT, synaptophysin) ( Figure 2 ). Fixation with a high concentration of glutaraldehyde was particularly valuable for combined immunodetection of a protein antigen with 5-HT, using a monoclonal antibody directed against a 5-HT-glutaraldehyde-protein conjugate, which requires such a fixation (15) (Figure 3 ).
Discussion
The present results demonstrate that the immunoreactivity of several peptides and of different types of proteins can be adequately maintained in brain tissue optimally preserved for electron microscopic analysis after fixation with 3.5 % glutaraldehyde.
Some of the antigens tested, such as TH and GAD (3) , , and PHA-L (25), had previously been shown to be resistant to glutaraldehyde, but others had long been considered very sensitive to this fixative. It has been reported, in particular, that ChAT immunoreactivity was undetectable if glutaraldehyde was added to 4% paraformaldehyde at a concentration greater than 0.05% (22). The combination of two different aldehydes therefore appears to be more detrimental than glutaraldehyde alone to the immunoreactivity of some antigens. Moreover, immunoreactivity to intermediate filament proteins (vimentin or GFAP in astrocytes and NF-L in neurons) not only appeared well-preserved by glutaraldehyde fixation but also, in the case of NF-L, was even improved compared with results obtained with a single paraformaldehyde fixation (23, 24) . Because neurofdaments are not readily soluble proteins, the better preservation of immunoreactivity with glutaraldehyde can hardly be attributed simply to an improved in situ retention of the antigen by the fixative.
One pitfall in immunocytochemistry, which was exacerbated in glutaraldehyde-fixed sections and may lead to underestimated results, is related to poor penetration of the immunoreagents. We noted, however, that this limitation was clearly dependent on the antigen under examination. Because we used the same sets of secondary antibodies, followed by the ABC complex, to reveal all monoclonal or polyclonal antibodies tested in this study, differences in the extent of immunostaining through the thickness of the sections can be attributed to the primary antibodies. Differential accessibility of the corresponding antigen is unlikely to be the main explanation for this phenomenon. Indeed, TH or GAD, which presumably should be equivalently accessible because they are located in similar cell compartments, represented two extremes of the .- penerration spectrum. Moreover, there were differences in the immunolabeling for the synaptic vesicle-associated proteins. Synaptophysin immunoreactivity, but not synapsin I immunoreactivity, was restricted to the surface of the vibratome sections. Because all lgGs are presumed to be of similar molecular weight (26) . some yet unidentified property of individual primary antibodies appears to be the determinant for their penetration into tissue sections. One possibility. for example, might be electrical charges that could limit the penetration of these molecules into tissue sections by aggregating antibodies together or by hindering their migration among other charged molecules.
In conclusion. immunocytochemistry can be successfully carried out to localize various peptide or protein antigens in glutaraldehydefixed brain tissue. The possibility to generalize the use of glutaraldehyde as a fixative for immunocytochemistry will be advantageous for studies at the electron microscopic level, since it is compatible with excellent preservation of brain tissue ultrastructure. It will also be useful for studies aimed at the combined detection of a protein with a second molecule, such as an amino acid or a biogenic amine (e.g.. 15.27) . requiring glutaraldehyde fixation for its retention in situ. ChAT in different brain structures after fixation with 3.5% glutaraldehyde. (A) Cerebral cortex: pyramidal perikarya and apical dendrites (arrows) labeled for NF-L in Layer 111. Note also the staining of many dendrites and axons in the neuropil. This staining was clearly more intense than in brain sections fixed with paraformaldehyde only. (E) Cerebral cortex (superficial layers); GAD immunostaining was present in some perikarya (curved arrows) and in a large number of axonal varicosities, of which many were in pericellular arrangements (straight arrows). (C) Septum: astrocytes immunostained for GFAP. (D) Neostriatum; two perikarya and a large number of varicose axons (arrows) immunoreactive for ChAT. Bars = 30 pm. 
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